ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction

Human Molecular Genetics

Volumn 14, Issue 21, 2005, Pages 3219-3225

  Huang, Guiqing ^a   Krig, Sheryl ^b   Kowbel, David ^a   Xu, Hongmei ^a   Hyun, Bill ^a   Volik, Stas ^a   Feuerstein, Burt ^a   Mills, Gordon B ^c   Stokoe, David ^a   Yaswen, Paul ^b   Collins, Colin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOXORUBICIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER STAGING; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHROMOSOME 20Q; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; DRUG SENSITIVITY; GENE AMPLIFICATION; GENE MAPPING; GENE SILENCING; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TELOMERE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 20; DNA DAMAGE; DNA PRIMERS; DOXORUBICIN; DRUG THERAPY; GENE SILENCING; HUMANS; IMMUNOBLOTTING; NEOPLASM PROTEINS; TELOMERE; TRANS-ACTIVATORS;

EID: 27744434068     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi352     Document Type: Article

References (26)

1. Kallioniemi, A., Kallioniemi, O.-P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H.S., Pinkel, D., Gray, J.W. and Waldman, F.M. (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl Acad. Sci. USA, 91, 2156-2160.
2. Werner, M., Mattis, A., Aubele, M., Cummings, M., Zitzelsberger, H., Hutzler, P. and Hofer, H. (1999) 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Virchows Arch., 435, 469-472.
3. Tanner, M., Tirkkonen, M., Kallioniemi, A., Holli, K., Collins, C., Kowbel, D., Gray, J.W., Kallioniemi, O.-P. and Isola, J. (1995) Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin. Cancer Res., 1, 1455-1461.
4. Collins, C., Volik, S., Kowbel, D., Ginzinger, D., Ylstra, B., Cloutier, T., Hawkins, T., Predki, P., Martin, C., Wernick, M. et al. (2001) Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res., 11, 1034-1042.
5. Schrock, E., Thiel, G., Lozanova, T., du Manoir, S., Meffert, M.C., Jauch, A., Speicher, M.R., Nurnberg, P., Vogel, S. and Janisch, W. (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol., 144, 1203-1218.
6. Ried, T., Knutzen, R., Steinbeck, R., Blegen, H., Schrock, E., Heselmeyer, K., du Manoir, S. and Auer, G. (1996) Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer, 15, 234-245.
7. Muleris, M., Almeida, A., Gerbault-Seureau, M., Malfoy, B. and Dutrillaux, B. (1994) Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer, 10, 160-170.
8. Schlegel, J., Stumm, G., Scherthan, H., Bocker, T., Zirngibl, H., Ruschoff, J. and Hofstadter, F. (1995) Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res., 55, 6002-6005.
9. Iwabuchi, H., Sakamoto, M., Sakunaga, H., Ma, Y.Y., Carcangiu, M.L., Pinkel, D., Yang-Feng, T.L. and Gray, J.W. (1995) Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res., 55, 6172-6180.
10. Collins, C., Rommens, J.M., Kowbel, D., Godfrey, T., Tanner, M., Hwang, S., Polikoff, D., Nonet, G., Cochran, J., Myambo, K. et al. (1998) Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc. Natl Acad. Sci. USA, 95, 8703-8708.
11. Pieler, T. and Bellefroid, E. (1994) Perspectives on zinc finger protein function and evolution - an update. Mol. Biol. Rep., 20, 1-8.
12. Iuchi, S. (2001) Three classes of C2H2 zinc finger proteins. Cell. Mol. Life Sci., 58, 625-635.
13. Laity, J.H., Lee, B.M. and Wright, P.E. (2001) Zinc finger proteins: New insights into structural and functional diversity. Curr. Opin. Struct. Biol., 11, 39-46.
14. Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Marcel, M., Huylebroeck, D. and van Roy, F. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell, 7, 1267-1278.
15. You, A., Tong, J.K., Grozinger, C.M. and Schreiber, S.L. (2001) CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc. Natl Acad. Sci. USA, 98, 1454-1458.
16. Shi, Y., Sawada, J., Sui, G., Affar el, B., Whetstine, J.R., Lan, F., Ogawa, H., Luke, M.P. and Nakatani, Y. (2003) Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature, 422, 735-738.
17. Grooteclaes, M., Deveraux, Q., Hildebrand, J., Zhang, Q., Goodman, R.H. and Frisch, S.M. (2003) C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc. Natl Acad. Sci. USA, 100, 4568-4573.
18. Savelieva, E., Belair, C.D., Newton, M.A., DeVries, S., Gray, J.W., Waldman, F. and Reznikoff, C.A. (1997) 20q gain associates with immmortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene, 14, 551-560.
19. Doroshow, J.H. (1996) Cancer Chemotherapy and Biotherapy. Lippincott-Raven, Philadelphia.
20. Nonet, G., Stampfer, M.R., Chin, K., Gray, J.W., Collins, C.C. and Yaswen, P. (2001) The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res., 61, 1250-1254.
21. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S. and de Lange, T. (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science, 283, 1321-1325.
22. Kishi, S., Wulf, G., Nakamura, M. and Lu, K.P. (2001) Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors. Oncogene, 20, 1497-1508.
23. Nicholson, K. and Anderson, NG. (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal., 14, 381-395.
24. Hanada, M., Feng, J. and Hemmings, BA. (2004) Structure, regulation and function of PKB/AKT - a major therapeutic target. Biochim. Biophys. Acta, 1697, 3-16.
25. Courjal, F., Cuny, M., Rodriguez, C., Louason, G., Speiser, P., Katsaros, D., Tanner, M.M., Zeillinger, R. and Theillet, C. (1996) DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br. J. Cancer, 74, 1984-1989.
26. Fang, X., Yu, S., LaPushin R., Lu, Y., Furui, T., Penn, L.Z., Stokoe, D., Erickson, J.R., Bast, R.C., Jr and Mills, G.B. (2000) Lysophosphatidic acid prevents apoptosis in fibroblasts via Gi-protein-mediated activation of mitogen-activated protein kinase. Biochem. J., 352, 135-143.